Justin Spencer, Chief Financial Officer at Eko Health
What You Should Know:
– Eko Health, a pioneer in AI-powered heart and lung disease detection, announced today the appointment of Justin Spencer as Chief Financial Officer (CFO).
–…
Continue Reading
AI technology is being rolled out at seven NHS trusts within the Greater Manchester Imaging Network to help doctors detect diseases, including lung cancer, quicker.
The solution from global health tech firm Annalise.ai uses AI-powered…
We developed an interpretable model, BOUND (Bayesian netwOrk for large-scale lUng caNcer Digital prescreening), using a comprehensive EHR dataset from the China to improve lung cancer detection rates. BOUND employs Bayesian network uncertainty inference,…
Continue Reading
Lunit collabs with AstraZeneca, secures major deal in France Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims…
Advancing precision in lung cancer diagnostics: Lunit’s collaboration with AstraZeneca aims to transform the speed and accuracy of detecting actionable mutations in NSCLC. (Courtesy of Lunit)
What You Should Know:
– Lunit, a provider of AI…
Continue Reading
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.According to a press statement, the following organisations will…
Continue Reading
What You Should Know:
– Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced the issuance of a Category III Current Procedural Terminology (CPT) code by the…
Continue Reading
What You Should Know:
– A new cancer treatment and research era is dawning in Japan with the launch of LC-SCRUM-CD (Lung Cancer Genome Screening Project for Individualized Medicine – Clinical Development).
– The nationwide clinical…
Continue Reading
What You Should Know:
– PrognomiQ, a healthcare company pioneering multi-omics approaches to disease detection, has secured $34M in Series D funding led by Seer, Inc., with participation from a new strategic investor and existing…
Continue Reading
What You Should Know:
– Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk assessment completion through a collaboration with CancerIQ, a best-in-class cancer-focused…
Continue Reading
